Review on Psoriasis Disease
Asian Journal of Pharmaceutical Research and Development · 2022
DOI: 10.22270/ajprd.v10i1.1084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Pharmaceutical Research and Development, 2022. Verfasst von Prashant S Malpure und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Psoriasis is an autoimmune disease characterised by the proliferation of keratinocytes throughout time. On average, it affects 2-5 percent of the world's population. Psoriasis treatment remains difficult due to a variety of factors influencing treatment, including patient compliance and adherence to therapy, delicate patient profiles, psychological factors, and skin as a barrier to topical delivery. Pathophysiology, triggering factors, and clinical categorization were covered in the first section. Topical, oral, biological, parenteral therapy, phototherapy, and phytopharmaceuticals were all covered in the second section.
Zitieren
APA
Malpure, P. S., Kadam, G. R., Chitte, S. D., & Kale, G. S. (2022). Review on Psoriasis Disease. Asian Journal of Pharmaceutical Research and Development. https://doi.org/10.22270/ajprd.v10i1.1084
Vancouver
Malpure PS, Kadam GR, Chitte SD, Kale GS. Review on Psoriasis Disease. Asian Journal of Pharmaceutical Research and Development. 2022. doi:10.22270/ajprd.v10i1.1084
BibTeX
@article{Malpure2022,
author = {Malpure, Prashant S and Kadam, Gayatri R and Chitte, Sakshi D and Kale, Gaurav S},
title = {Review on Psoriasis Disease},
journal = {Asian Journal of Pharmaceutical Research and Development},
year = {2022},
doi = {10.22270/ajprd.v10i1.1084}
}
EUVIMED